These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 2160137

  • 1. Effects of oral erythrosine (2',4',5',7'-tetraiodofluorescein) on the pituitary-thyroid axis in rats.
    Jennings AS, Schwartz SL, Balter NJ, Gardner D, Witorsch RJ.
    Toxicol Appl Pharmacol; 1990 May; 103(3):549-56. PubMed ID: 2160137
    [Abstract] [Full Text] [Related]

  • 2. Effects of oral erythrosine (2',4',5',7'-tetraiodofluorescein) on thyroid function in normal men.
    Gardner DF, Utiger RD, Schwartz SL, Witorsch P, Meyers B, Braverman LE, Witorsch RJ.
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):299-304. PubMed ID: 2447681
    [Abstract] [Full Text] [Related]

  • 3. Sequential changes in the pituitary thyroid axis after chronic TRH administration: effects on euthyroid and thyroxine treated female rats.
    Iglesias R, Llobera M, Montoya E.
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):237-42. PubMed ID: 3925674
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).
    Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, Lau C, Singh RJ, Wallace KB, Butenhoff JL.
    Toxicology; 2008 Jan 20; 243(3):330-9. PubMed ID: 18063289
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of neonatal exposure to TRH on development of the pituitary-thyroid axis in rats.
    Kawai Y, Azukizawa M, Ashida N, Kumahara Y, Miyai K.
    Acta Endocrinol (Copenh); 1983 Oct 20; 104(2):201-5. PubMed ID: 6415989
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Augmentation of thyrotropin responses to thyrotropin-releasing hormone following small decreases in serum thyroid hormone concentrations.
    Saberi M, Utiger RD.
    J Clin Endocrinol Metab; 1975 Mar 20; 40(3):435-41. PubMed ID: 803974
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of TSH-stimulated thyroid hormone release and potentiation of TRH-stimulated TSH release by indomethacin in perifusion systems of rat thyroids and pituitaries.
    Mashita K, Tajima K, Kawamura S, Tarui S.
    Experientia; 1984 Dec 15; 40(12):1429-31. PubMed ID: 6439574
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aspects of chronic oral treatment with thyrotropin-releasing hormone: the hypothalamic-pituitary-thyroid axis in rats. A study with a pharmacological dose of thyrotropin-releasing hormone.
    Duntas L, Roussel JP, Astier H, Keck FS, Rosenthal J, Pfeiffer EF.
    Pharmacology; 1991 Dec 15; 43(2):106-12. PubMed ID: 1775509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.